Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

National Center for Research & Development

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 45
Average round size
info
The average size of a deal this fund participated in
$1M
Portfolio companies 36
Rounds per year 2.81
Lead investments 3
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.20
Exits 3
Key employees Soon
Stages of investment
Grant

Areas of investment

  • Artificial Intelligence
  • Software
  • Information Technology
  • Health Care
  • Hardware
Summary

National Center for Research & Development is the famous Corporate Investor, which was founded in 2007. The venture was found in Europe in Poland. The main office of represented Corporate Investor is situated in the Warszawa.

The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the National Center for Research & Development, startups are often financed by EASME - EU Executive Agency for SMEs, Boost VC, Black Pearls VC. The meaningful sponsors for the fund in investment in the same round are European Commission. In the next rounds fund is usually obtained by ff Venture Capital, Techstars, RTAventures VC.

The top activity for fund was in 2017. Despite it in 2019 the fund had an activity. The increased amount of exits for fund were in 2017. Comparing to the other companies, this National Center for Research & Development performs on 19 percentage points less the average number of lead investments. The real fund results show that this Corporate Investor is 20 percentage points more often commits exit comparing to other companies. The common things for fund are deals in the range of 1 - 5 millions dollars. The fund is generally included in 2-6 deals every year.

The fund has no exact preference in some founders of portfolio startups. If startup sums 3 or 4 of the founder, the chance for it to be financed is low. Among the most successful fund investment fields, there are Artificial Intelligence, Software. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight APPLICA.AI, Billon Group, XTPL. For fund there is a match between the location of its establishment and the land of its numerous investments - Poland.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of National Center for Research & Development:
Typical Co-investors
National Center for Research & Development is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after National Center for Research & Development:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from Poland
Funds with similar focus located in Poland:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
There are no funds here. If we find new data, we will add it here.
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Cambrian Biopharma New York, New York, United States
CPC & Partners Canada, Ontario, Toronto
E3 Capital Partners California, Los Angeles, United States
Galaxy Internet Beijing, Beijing, China
Huahong Asset Beijing, Beijing, China
Kateeva California, Newark, United States
Nanyang Ventures Australia, New South Wales, Sydney
Neev Fund India, Maharashtra, Mumbai
Newegg California, City Of Industry, United States
Palisades Technology Partners Englewood Cliffs, New Jersey, United States
Parkview Ventures New York, New York, United States
PWP Growth Equity New York, New York, United States
Success Group China, Foshan, Guangdong
Swarraton Partners England, London, United Kingdom
The Melohn Group -
University at Buffalo Buffalo, New York, United States
University of Pittsburgh Innovation Institute Pennsylvania, Pittsburgh, United States
Xinghao Venture Management Center -
Xinyuan Investment -
Xpanasia -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

BioCam

Health Care
Health Diagnostics
Medical
Medical Device
Software
$1M30 Jun 2021 Wroclaw, Lower Silesian Voivodeship, Poland

Healthcann

Biopharma
Cannabis
$1M11 Feb 2021 Wroclaw, Dolnoslaskie, Poland

AILIS Breast Cancer Prediction Technology

Artificial Intelligence
Health Care
Health Diagnostics
Medical Device
$1M01 Dec 2020 Kraków, Malopolskie, Poland

Airly

CleanTech
Data Visualization
Hardware
Internet of Things
Smart Cities
$2M02 Oct 2020 Krakow, Lesser Poland Voivodeship

ICSEC

Cyber Security
Industrial
Information Technology
Network Security
Security
Software
$1M31 Jan 2020 Poznan, Wielkopolskie, Poland

SmartLife Robotics

Artificial Intelligence
EdTech
Information Technology
Robotics
Software
$260K31 Jul 2019 Warsaw, Mazowieckie, Poland

AILIS Breast Cancer Prediction Technology

Artificial Intelligence
Health Care
Health Diagnostics
Medical Device
$1M01 Jan 2018 Kraków, Malopolskie, Poland

FSE Fabryka Samochodów Elektrycznych Sp. z o.o.

Automotive
Electric Vehicle
Manufacturing
$1M20 May 2017 Bielsko-Biała, Silesian Voivodeship, Poland

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent National Center for Research & Development?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 45
Average round size 1M
Rounds per year 2.81
Peak activity year 2021
Lead investments 3
Follow on index 0.20
Exits 3
Group Appearance index 0.22

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

BioCam

Health Care
Health Diagnostics
Medical
Medical Device
Software
$1M30 Jun 2021 Wroclaw, Lower Silesian Voivodeship, Poland

Healthcann

Biopharma
Cannabis
$1M11 Feb 2021 Wroclaw, Dolnoslaskie, Poland

AILIS Breast Cancer Prediction Technology

Artificial Intelligence
Health Care
Health Diagnostics
Medical Device
$1M01 Dec 2020 Kraków, Malopolskie, Poland

Airly

CleanTech
Data Visualization
Hardware
Internet of Things
Smart Cities
$2M02 Oct 2020 Krakow, Lesser Poland Voivodeship

ICSEC

Cyber Security
Industrial
Information Technology
Network Security
Security
Software
$1M31 Jan 2020 Poznan, Wielkopolskie, Poland

SmartLife Robotics

Artificial Intelligence
EdTech
Information Technology
Robotics
Software
$260K31 Jul 2019 Warsaw, Mazowieckie, Poland

AILIS Breast Cancer Prediction Technology

Artificial Intelligence
Health Care
Health Diagnostics
Medical Device
$1M01 Jan 2018 Kraków, Malopolskie, Poland

FSE Fabryka Samochodów Elektrycznych Sp. z o.o.

Automotive
Electric Vehicle
Manufacturing
$1M20 May 2017 Bielsko-Biała, Silesian Voivodeship, Poland
Crunchbase icon

Content report

The following text will be sent to our editors: